Borea Therapeutics is a startup, 1 tracked investor.
Borea Therapeutics is a startup. Brouky records 1 investor associated with the company.
Borea Therapeutics develops innovative therapeutic options for patients with genetic or chronic diseases using next-generation viral vectors, leveraging a proprietary click chemistry platform to chemically modify adeno-associated virus (AAV) vectors.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.